Literature DB >> 12227693

Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease.

V Rauta1, P Finne, J Fagerudd, K Rosenlöf, T Törnroth, C Grönhagen-Riska.   

Abstract

BACKGROUND: A number of factors are linked to the outcome of IgA nephropathy (IgAN). However, it has been difficult to compare results of studies since patient populations have varied greatly. There were 3 aims in the study reported here, namely to compare factors associated with renal outcome in IgAN patients with different levels of renal function on diagnosis; to determine factors which were independently associated with progression of renal disease in initially mild IgAN; and to create a model for the estimation of the risk of progression in individual IgAN patients with normal renal function on diagnosis.
METHODS: Two hundred and fifty-nine IgAN patients who had been followed on average for 9.1 (SD 4.5) after diagnosis were divided into 2 groups on the basis of renal function on diagnosis. In group 1 (98 patients), Ccr (creatinine clearance, estimated by the Cockcroft-Gault formula) was < 85 ml/min, in group 2 (161 patients) > or = 85 ml/min. Univariate analyses were used to find significant differences between progressors and non-progressors in both groups. Logistic regression analysis was used to determine factors independently associated with progression in group 2.
RESULTS: Several factors were found to be associated with outcome in both groups, such as hypertension, level of Ccr, serum cholesterol, proteinuria, and also histopathological changes. Factors associated with progression in patients with initially decreased renal function (group 1), were predictable, such as male sex, absence of episodes of macroscopic hematuria, serum urate level and degree of tubular atrophy. Surprisingly, in patients with initially normal renal function (group 2), numbers of urinary erythrocytes were associated with outcome. The factors independently associated with progression in this group were number of urinary erythrocytes, existence of hypertension and in histopathology arteriolosclerosis and the level of glomerular score. A model for estimating risk of progression on the basis of various combinations of factors found to be independently associated with outcome is presented.
CONCLUSIONS: We concluded that association between variable and outcome in IgAN depends partly on renal function at the time of assessment of the factor. Since there are factors which are independently associated with the outcome of early and apparently mild disease, early diagnosis of IgAN is desirable: outcome in mild IgAN can be predicted reliably on the basis of factors found to be independently associated with outcome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12227693     DOI: 10.5414/cnp58085

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  15 in total

1.  Long-term results of a randomized controlled trial in childhood IgA nephropathy.

Authors:  Koichi Kamei; Koichi Nakanishi; Shuichi Ito; Mari Saito; Mayumi Sako; Kenji Ishikura; Hiroshi Hataya; Masataka Honda; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 8.237

2.  Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.

Authors:  Kayu Tanaka; Takahito Moriyama; Chihiro Iwasaki; Takashi Takei; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2014-12-05       Impact factor: 2.801

3.  Comparison between steroid pulse therapy alone and in combination with tonsillectomy for IgA nephropathy.

Authors:  Ayami Ochi; Takahito Moriyama; Takashi Takei; Keiko Uchida; Kosaku Nitta
Journal:  Int Urol Nephrol       Date:  2012-07-26       Impact factor: 2.370

4.  A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy.

Authors:  Khalil El Karoui; Gary S Hill; Alexandre Karras; Christian Jacquot; Luc Moulonguet; Olivier Kourilsky; Véronique Frémeaux-Bacchi; Michel Delahousse; Jean-Paul Duong Van Huyen; Alexandre Loupy; Patrick Bruneval; Dominique Nochy
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

5.  Significance of the duration of nephropathy for achieving clinical remission in patients with IgA nephropathy treated by tonsillectomy and steroid pulse therapy.

Authors:  Norio Ieiri; Osamu Hotta; Toshinobu Sato; Yoshio Taguma
Journal:  Clin Exp Nephrol       Date:  2011-09-13       Impact factor: 2.801

6.  Comparison between consecutive and intermittent steroid pulse therapy combined with tonsillectomy for clinical remission of IgA nephropathy.

Authors:  Daigo Kamei; Takahito Moriyama; Takashi Takei; Sachiko Wakai; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2013-06-07       Impact factor: 2.801

7.  Predicting the risk for dialysis or death in IgA nephropathy.

Authors:  François Berthoux; Hesham Mohey; Blandine Laurent; Christophe Mariat; Aida Afiani; Lise Thibaudin
Journal:  J Am Soc Nephrol       Date:  2011-01-21       Impact factor: 10.121

8.  Prediction of diagnosis of immunoglobulin A nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading.

Authors:  Kazutaka Nakayama; Isao Ohsawa; Atsuko Maeda-Ohtani; Maki Murakoshi; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

9.  Renal interstitial infiltration and tertiary lymphoid organ neogenesis in IgA nephropathy.

Authors:  Guangchang Pei; Rui Zeng; Min Han; Panli Liao; Xuan Zhou; Yueqiang Li; Ying Zhang; Ping Liu; Chunxiu Zhang; XiaoCheng Liu; Ying Yao; Gang Xu
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 8.237

10.  Natural history and renal pathology in patients with isolated microscopic hematuria.

Authors:  Byung Soo Kim; Yong Kyun Kim; Young Shin Shin; Young Ok Kim; Ho Cheol Song; Yong Soo Kim; Euy Jin Choi
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.